Caterpillar surrendered the ground it had been quietly rebuilding — closing Tuesday at $840.87, down 4.6% on the day and erasing the modest gains of the prior week — and the selloff is not a CAT-specific story.
Every close peer fell sharply on the same session. TEX dropped 4.3% and OSK fell 4.1% on the day, while NPO shed nearly 4.9%. CMI lost 3.2%. The pattern points to a broad cyclical rotation rather than a Caterpillar-specific event. CAT is now down 4.5% on the month, having given back a chunky portion of its post-Q2 recovery. The stock peaked above $933 before the July drawdown; even at last week's close of $856 it was well off that level, and Tuesday's print at $841 extends the slide.
The positioning backdrop offers little drama. Short interest has been unwinding steadily — it's now just 1.45% of free float, down 6% on the week and 17% versus a month ago. Bears who built positions around the July earnings weakness have largely exited. The borrow market reflects that: cost to borrow is a negligible 0.43%, and availability is essentially unlimited, with shares available to lend running at multiples of current short demand. There is no squeeze pressure, no sign of fresh short conviction, and no tightening in the lending pool. The ORTEX short score of 30.2 sits well below the midpoint, consistent with a stock that is not attracting meaningful short-side attention. Options positioning is mildly elevated — the put/call ratio is 1.08, a touch above its 20-day average of 1.06 — but the z-score of 1.1 is nowhere near alarming. Investors are not rushing to buy downside protection.
The Street remains broadly constructive, but cracks are appearing at the margin. The mean price target is $979, implying roughly 16% upside from Tuesday's close — a gap that has widened again as the stock has retreated. Most firms that moved post-earnings went in one direction: UBS lifted to $925, Barclays raised to $900, and Truist reiterated its Buy with a target nudged to $1,225. But the last word from a high-conviction bull came from Evercore ISI's David Raso, who cut his target from $1,103 to $1,045 just last week while keeping his Outperform rating — the clearest signal yet that even the believers are trimming their ambitions. Baird went further on July 29, downgrading outright to Neutral from Outperform and slashing its target from $1,200 to $900, citing tariff headwinds. The bear case is concrete: $800 million in incremental tariff costs have already compressed construction segment margins by 470 basis points and resource margins by 510 basis points year-over-year. Against that, the bull case rests on a 71% year-over-year surge in backlog to $51.2 billion and a 22.9% rise in Power and Energy segment sales — signals that end-demand has not collapsed, even if near-term profitability is under pressure. Factor scores lean positive on earnings momentum — 88th percentile on 30-day EPS momentum and 80th percentile on EPS surprise — but the forward earnings growth rank sits at just 40, and the valuation is not cheap: PE near 28x and EV/EBITDA around 21.7x leave little margin for error if the tariff drag persists.
The Q3 earnings date is penciled in for October 29. The last two prints produced opposite reactions — a 4.9% gain on the August 4 Q2 release and a 2.2% fall on the prior quarter — suggesting the stock is genuinely binary into results and that the tariff line item will be the number the market focuses on. Between now and then, how the broader machinery group trades around any new tariff developments or infrastructure spending signals is the most important context to watch.
See the live data behind this article on ORTEX.
Open CAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
